26K views · 210 reactions | JUST IN: New trial data shows that Oxford University's COVID-19 vaccine produces a strong immune response in older adults. #9News | 9 News | Facebook

🆕| Oxford University begins HIV vaccine trial A Phase I trial began today to evaluate the safety, tolerability, & immunogenicity of the HIVconsvX vaccine. It targets a broad range of HIV-1 variants - so it could have an effect on HIV strains in any geographical region. More info ⬇️ https://bit.ly/2VbeS4Y | University of Oxford

BREAKING: Results from phase one of trials of a #COVID19 vaccine being developed at the University of Oxford, show it induces an immune reaction. Sky's Sadiya Chowdhury has the latest. Find out more here: https://trib.al/C7RzS4l | Sky News

The first trials are taking place to study the effectiveness of the Oxford Covid vaccine in children, with 300 volunteers aged six to 17 taking part in the research. Keme Nzerem reports. | Channel 4 News

"It’s an incredible thing to be part of a study that will hopefully develop a vaccine." Hear from Dr Maheshi Ramasamy about her work on the clinical trials for the Oxford #COVID19 vaccine. Watch 👇 University of Oxford | Oxford Vaccine Group, Department of Paediatrics, University of Oxford | Jenner Institute Vaccine Trials, University of Oxford | Department of Health and Social Care - DHSC